BGF World Healthscience A2 EUR H/ LU1822774284 /
NAV7/1/2022 | Chg.+0.0600 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
13.6900EUR | +0.44% | reinvestment | Equity Worldwide | BlackRock (LU) ▶ |
Monthly performance
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2018 | - | - | - | - | - | - | 3.87 | 3.82 | 2.39 | -6.47 | 4.32 | -7.73 | - |
2019 | 4.39 | 2.87 | -0.09 | -3.44 | -1.93 | 6.68 | 1.84 | -0.45 | -1.73 | 4.44 | 4.16 | 2.63 | +20.56% |
2020 | -0.41 | -8.65 | -3.37 | 11.49 | 3.55 | -1.55 | 5.80 | 1.17 | -1.47 | -5.03 | 8.02 | 3.52 | +11.92% |
2021 | 1.63 | -2.62 | 1.27 | 4.72 | 0.85 | 2.38 | 1.84 | 1.61 | -4.49 | 2.07 | -2.50 | 6.11 | +13.09% |
2022 | -8.31 | -0.64 | 5.89 | -3.46 | -1.83 | -2.50 | 0.44 | - | - | - | - | - | - |
Calculated values
YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
---|---|---|---|---|---|
Volatility | 19.44% | 19.51% | 15.81% | 17.00% | -% |
Sharpe ratio | -1.01 | -0.87 | -0.44 | 0.46 | - |
Best month | +6.11% | +5.89% | +6.11% | +11.49% | +11.49% |
Worst month | -8.31% | -8.31% | -8.31% | -8.65% | -8.65% |
Maximum loss | -16.61% | -15.95% | -16.67% | -26.44% | - |
Outperformance | -4.60% | - | -0.01% | +7.29% | - |
All quotes in EUR
Tranches
Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
---|---|---|---|---|---|
BGF World Healthscience A2 AUD H | reinvestment | 20.2400 | -6.77% | +25.79% | |
BGF World Healthscience A2 HKD H | reinvestment | 208.1500 | -6.11% | +30.53% | |
BGF World Healthscience A2 SGD H | reinvestment | 20.6600 | -6.01% | +28.80% | |
BGF World Healthscience C2 EUR | reinvestment | 45.1300 | +6.26% | +37.68% | |
BGF World Healthscience A2 CNH H | reinvestment | 178.8500 | -3.94% | +37.30% | |
BGF World Healthscience D2 USD | reinvestment | 67.8000 | -5.06% | +34.26% | |
BGF World Healthscience D2 EUR | reinvestment | 65.1900 | +8.43% | +46.20% | |
BGF World Healthscience D4 EUR | paying dividend | 15.4600 | -5.04% | +34.26% | |
BGF World Healthscience X2 USD | reinvestment | 75.8100 | -4.12% | +38.31% | |
BGF World Healthscience E2 USD | reinvestment | 54.6500 | -6.24% | +29.32% | |
BGF World Healthscience A4 EUR | paying dividend | 11.0100 | +7.52% | - | |
BGF World Healthscience A4 USD | paying dividend | 11.4600 | -5.76% | - | |
BGF World Healthscience A2 EUR H | reinvestment | 13.6900 | -7.12% | +24.68% | |
BGF World Healthscience E2 EUR | reinvestment | 52.5400 | +7.07% | +40.82% | |
BGF World Healthscience A2 USD | reinvestment | 60.6900 | -5.78% | +31.25% | |
BGF World Healthscience A2 EUR | reinvestment | 58.3500 | +7.60% | +42.94% |
Performance
YTD | -10.46% | ||
---|---|---|---|
6 Months | -8.79% | ||
1 Year | -7.12% | ||
3 Years | +24.68% | ||
5 Years | - | ||
Since start | +36.90% | ||
Year | |||
2021 | +13.09% | ||
2020 | +11.92% | ||
2019 | +20.56% |